Who has invested in Nuclidium?

No investors are named on the public record for Nuclidium yet.

Nuclidium Funding: $134M Raised, Series B (2025)

Nuclidium funding overview

Nuclidium is based in Basel, Switzerland. Nuclidium has raised $134M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2025. The round record for Nuclidium runs through 2025; nothing later has been disclosed.

Nuclidium at a glance

Total raised: $134M
Latest round: Series B
Latest round date: June 2025
Headquarters: Basel, Switzerland

Frequently asked about Nuclidium funding

How much has Nuclidium raised?: Nuclidium has raised $134M in total disclosed funding across the rounds on record.
Who has invested in Nuclidium?: No investors are named on the public record for Nuclidium yet.
What was the latest Nuclidium funding round?: The most recent disclosed round is a Series B, announced in June 2025.
Where is Nuclidium based?: Nuclidium is based in Basel, Switzerland.
When did Nuclidium last raise?: The last disclosed Nuclidium round closed in June 2025 at Series B.

Round data for Nuclidium is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Basel and backer lists below.

Nuclidium Funding: $134M Raised, Series B (2025)

Nuclidium funding overview

Nuclidium at a glance

Frequently asked about Nuclidium funding

Companies related to Nuclidium (17)

Browse related funding lists (3)